LENZ NASDAQ
LENZ Therapeutics, Inc.
1W: -8.7%
1M: -38.3%
3M: -36.1%
YTD: -77.6%
1Y: -92.7%
$3.58
-0.21 (-5.54%)
Weekly Expected Move ±8.8%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$112.2M
52W Range3.51-49.85
Volume1,126,304
Avg Volume820,790
Beta1.63
Dividend—
Analyst Ratings
Company Info
CEOEvert Schimmelpennink
Employees152
SectorHealthcare
IndustryBiotechnology
IPO Date2021-06-25
Websitelenz-tx.com
201 Lomas Santa Fe Drive
Solana Beach, CA 92075
US
Solana Beach, CA 92075
US
(858) 925-7000
About LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
Latest News
AM Markets Need to Know: F-35 parts end up in Chinese custody, Google nears Gemini 4 launch, and more
Gene editing stocks fall after Anthropic’s CRISPR-like discovery
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Aug 2026
Bank of America Corp DE Boosts Stock Position in LENZ Therapeutics, Inc. $LENZ
LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| RA CAPITAL MANAGEMEN | A-Award | 22,100 | $6.63 | 2026-06-15 |
| George Jeffrey P. | A-Award | 22,100 | $6.63 | 2026-06-15 |
| Drapkin Kimberlee C | A-Award | 22,100 | $6.63 | 2026-06-15 |
| MCCOLLUM JAMES W | A-Award | 22,100 | $6.63 | 2026-06-15 |
| Thunen Shelley B | A-Award | 22,100 | $6.63 | 2026-06-15 |